ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

  1. Mensali, N.
  2. Köksal, H.
  3. Joaquina, S.
  4. Wernhoff, P.
  5. Casey, N.P.
  6. Romecin, P.
  7. Panisello, C.
  8. Rodriguez, R.
  9. Vimeux, L.
  10. Juzeniene, A.
  11. Myhre, M.R.
  12. Fåne, A.
  13. Ramírez, C.C.
  14. Maggadottir, S.M.
  15. Duru, A.D.
  16. Georgoudaki, A.-M.
  17. Grad, I.
  18. Maturana, A.D.
  19. Gaudernack, G.
  20. Kvalheim, G.
  21. Carcaboso, A.M.
  22. de Alava, E.
  23. Donnadieu, E.
  24. Bruland, Ø.S.
  25. Menendez, P.
  26. Inderberg, E.M.
  27. Wälchli, S.
  28. Show all authors +
Journal:
Nature Communications

ISSN: 2041-1723

Year of publication: 2023

Volume: 14

Issue: 1

Type: Article

DOI: 10.1038/S41467-023-39097-X GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus